167 related articles for article (PubMed ID: 29241475)
1. Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.
Solter E; Adler A; Rubinovitch B; Temkin E; Schwartz D; Ben-David D; Masarwa S; Carmeli Y; Schwaber MJ
Infect Control Hosp Epidemiol; 2018 Jan; 39(1):85-89. PubMed ID: 29241475
[TBL] [Abstract][Full Text] [Related]
2. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
Schwaber MJ; Carmeli Y
Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
[TBL] [Abstract][Full Text] [Related]
3. National Policy for Carbapenem-Resistant Enterobacteriaceae (CRE) Clearance and Discontinuation of Contact Precautions for CRE Carriers in Post-Acute Care Hospitals in Israel: Impact on Isolation-Days and New Acquisitions.
Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
Clin Infect Dis; 2021 Mar; 72(5):829-835. PubMed ID: 32034414
[TBL] [Abstract][Full Text] [Related]
4. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
Ben-David D; Masarwa S; Adler A; Mishali H; Carmeli Y; Schwaber MJ
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):802-9. PubMed ID: 24915207
[TBL] [Abstract][Full Text] [Related]
5. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities.
Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
Clin Infect Dis; 2019 Mar; 68(6):964-971. PubMed ID: 29986007
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V
Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334
[TBL] [Abstract][Full Text] [Related]
8. The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
Schwaber MJ; Carmeli Y
Clin Infect Dis; 2017 Nov; 65(12):2144-2149. PubMed ID: 29020228
[TBL] [Abstract][Full Text] [Related]
9. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
12. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
Correa AAF; Fortaleza CMCB
Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
[TBL] [Abstract][Full Text] [Related]
15. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
Richter SS; Marchaim D
Virulence; 2017 May; 8(4):417-426. PubMed ID: 27813699
[TBL] [Abstract][Full Text] [Related]
16. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
[TBL] [Abstract][Full Text] [Related]
17. The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.
Toth DJA; Khader K; Slayton RB; Kallen AJ; Gundlapalli AV; O'Hagan JJ; Fiore AE; Rubin MA; Jernigan JA; Samore MH
Clin Infect Dis; 2017 Aug; 65(4):581-587. PubMed ID: 28472233
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
Livorsi DJ; Chorazy ML; Schweizer ML; Balkenende EC; Blevins AE; Nair R; Samore MH; Nelson RE; Khader K; Perencevich EN
Antimicrob Resist Infect Control; 2018; 7():55. PubMed ID: 29719718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
